HOME ·

WUXI BIO

HANSOH's ADC Licensing Deal with Roche Worth up to USD 15 Billion and a Record Share of Chinese Studies at ESMO LBA; CSOP Hang Seng Biotech ETF (03174.HK) Rises 2.09% Against the Trend on 20 October
Tags：
GENSCRIPT BIOASCENTAGEWUXI BIOHANSOH PHARMACSOP Hang Seng Biotech ETF
2026-10-20
Biotech Index Hits a Year-to-Date High as Innovative Drug and CXO Names Rally; CSOP Hang Seng Biotech ETF (3174.HK) Gains 3.18% and Is Up 17.93% Year-to-Date
Tags：
WUXI BIOAKESOSBP GROUP
2026-10-06
WUXI BIO(02269.HK): 2026 Interim Report - Profit Attributable to Shareholders stood at CNY 2.44 billion, YoY increase of 4.3%
Tags：
WUXI BIO02269.HKprofit growth
2026-08-25
WUXI BIO(02269.HK) will spend HKD 49.24 million to repurchase 1.6 million shares on Jun 22, 2026
Tags：
WUXI BIO02269.HKShare Repurchase
2026-06-23
WUXI BIO(02269.HK) will spend HKD 99.82 million to repurchase 3.04 million shares on Jun 5, 2026
Tags：
WUXI BIO02269.HK
2026-06-08
WUXI BIO(02269.HK) will spend HKD 49.89 million to repurchase 1.51 million shares on Jun 3, 2026
Tags：
WUXI BIO02269.HKShare Repurchase
2026-06-04